» Articles » PMID: 36457030

Effect of Ovarian Growth Factors on Ultra-structural Maturation in Frozen Human Immature Oocytes After in Vitro Maturation: a Comparative Study

Overview
Journal Reprod Health
Publisher Biomed Central
Date 2022 Dec 2
PMID 36457030
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In artificial reproductive technique (ART), nearly 20% of human oocytes are immature in the germinal vesicle (GV) phase. Consequently, the best method for reserving them is cryopreserving GV oocytes, and in vitro maturation (IVM) is recommended. The aim of this study was to determine the ultrastructure characteristics of fresh and vitrified immature human oocytes after in vitro maturation in conditioned mediums.

Methods: This study was a comparative laboratory study carried out in 2018 at Afzalipur Infertility Center in Kerman. 170 fresh and 198 vitrified GV oocytes were cultured within three IVM mediums; α-mem as control medium, α-mem supplemented with human bone marrow mesenchymal stem cells (BM-MSCs) and α-mem supplemented with ovarian growth factors (O.F). After 48 h, the maturation rate and morphological feature of IVM oocytes [132 fresh IVM (fIVM) and 134 vitrified IVM (vIVM)] were evaluated. For the ultrastructure study, 10 IVM oocytes from each medium were compared with 10 fresh in vivo oocytes cancelled from ART.

Results: The survival rate of vitrified GV oocyte after thawing was 88.88%. The oocyte maturation rate was reduced in vIVM compared to the fIVM group (76.33% vs. 77.95%); the highest oocyte maturation rate in the O.F fIVM and lowest in α-mem vIVM (82.35% vs. 71.42%). The lowest number of cortical granules was observed in α-mem vIVM, but the greatest presence of M-SER aggregates was in O.F fIVM. In vIVM oocytes, the oolemma contained irregular little microvillus organization.

Conclusions: The O.F mediums have shown the highest maturation which defends the oocyte ultra-structural conservation.

Citing Articles

Effects of different sperm sources on the clinical outcomes of oocyte maturation cycles combined with intracytoplasmic sperm injection.

Li J, Chen J, Tian S, Jiao T, Wang J, Wei Y Front Endocrinol (Lausanne). 2023; 14:1115210.

PMID: 36891059 PMC: 9986477. DOI: 10.3389/fendo.2023.1115210.

References
1.
Namavar Jahromi MD B, Parsanezhad MD M, Shomali MD Z, Bakhshai MD P, Alborzi MD M, Moin Vaziri MD PhD N . Ovarian Hyperstimulation Syndrome: A Narrative Review of Its Pathophysiology, Risk Factors, Prevention, Classification, and Management. Iran J Med Sci. 2018; 43(3):248-260. PMC: 5993897. View

2.
Fernandez-Reyez F, Ducolomb Y, Romo S, Casas E, Salazar Z, Betancourt M . Viability, maturation and embryo development in vitro of immature porcine and ovine oocytes vitrified in different devices. Cryobiology. 2012; 64(3):261-6. DOI: 10.1016/j.cryobiol.2012.02.009. View

3.
Boonkusol D, Faisaikarm T, Dinnyes A, Kitiyanant Y . Effects of vitrification procedures on subsequent development and ultrastructure of in vitro-matured swamp buffalo (Bubalus bubalis) oocytes. Reprod Fertil Dev. 2007; 19(2):383-91. DOI: 10.1071/rd06097. View

4.
Boots C, Meister M, Cooper A, Hardi A, Jungheim E . Ovarian stimulation in the luteal phase: systematic review and meta-analysis. J Assist Reprod Genet. 2016; 33(8):971-80. PMC: 4974222. DOI: 10.1007/s10815-016-0721-5. View

5.
Sun L, Li D, Song K, Wei J, Yao S, Li Z . Exosomes derived from human umbilical cord mesenchymal stem cells protect against cisplatin-induced ovarian granulosa cell stress and apoptosis in vitro. Sci Rep. 2017; 7(1):2552. PMC: 5451424. DOI: 10.1038/s41598-017-02786-x. View